Navigation Links
A Balanced Risk-Benefit Profile Will Propel Orexigen/Takeda's Contrave to Become the Most Widely Used Emerging Therapy for the Treatment of Obese and Overweight Patients
Date:11/6/2013

BURLINGTON, Mass., Nov. 6, 2013 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that novel emerging agents will experience steady uptake owing to the high prevalence of obese or overweight individuals and the current lack of efficacious, safe and well-tolerated weight-loss drugs. However, none of the emerging therapies are set to dominate the space owing to historical safety concerns that have fostered a cautious attitude among physicians and regulatory authorities, particularly in markets outside the United States.

(Logo: http://photos.prnewswire.com/prnh/20130103/MM36784LOGO )

The Pharmacor advisory service entitled Obesity finds that Orexigen/Takeda's Contrave will become the most widely used emerging therapy due to the fact it offers the best available balance of efficacy and safety among the competing therapeutic entities. A 3.0 mg formulation of Novo Nordisk's Victoza will become the sales leader over the 2012-2022 forecast period, owing to its premium price combined with physician familiarity and the additional metabolic benefits the drug provides. The U.S. launches of Vivus's Qsymia and Arena Pharmaceuticals/Eisai's Belviq in 2012 and 2013, respectively, have both been met with modest uptake, suggesting that historical safety issues associated with antiobesity agents still weigh on the minds of physicians. European and Japanese physicians will also have new treatments available from early in the forecast period, although they will continue to have fewer options from which to choose than their U.S. counterparts.

Decision Resources forecasts that the obesity drug market will grow more than fivefold over the next decade to ex
'/>"/>

SOURCE Decision Resources
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Positive Preclinical Profile of RG-101, a GalNAc-conjugated anti-miR Targeting microRNA-122, Supports Clinical Development for the Treatment of HCV
2. Data From Post-Hoc Analyses Presented at EASD Examine Safety Profile of Linagliptin in Adults with Type 2 Diabetes
3. Emerging Drug Delivery Technologies, Profiles of Start-ups and Early-Stage Companies
4. KemPharms KP201 Demonstrates Complete Metabolic Cleavage of Prodrug and Steady-State Pharmacokinetic Profiles for Hydrocodone, Hydromorphone and Acetaminophen
5. After Reviewing Brief Product Profiles, Surveyed Physicians Believe that Likely Candidates for Late-Phase Chronic Kidney Disease Products from AbbVie, Mitsubishi Tanabe, Eli Lilly, Concert, Fibrogen and Pfizer are Typically Stage 3b and 4 Patients
6. Apama Medical Announces Issuance Of Patent For Low Profile Electrodes For Use On Balloons
7. CTI Announces New Data Presented at EHA 2013 Congress Demonstrating the Safety and Tolerability Profile of Pacritinib in Patients with Myelofibrosis
8. Bioabsorbable Stents - Global Strategic Business Report - 2013 Profiles 16 Companies inside the Market
9. For Treating Psoriatic Arthritis, Clinical Data and Thought Leaders Opinions Indicate that AbbVie/Eisais Humira Has the Best Clinical Profile Among Key Marketed Therapies
10. Auxilium Pharmaceuticals Completes Acquisition Of Actient Holdings LLC To Create A Leading Urology Franchise With A Diversified Product Portfolio And Strong Growth Profile
11. Exosome Presents Late-Breaking Study Demonstrating Ability to Profile RNA from Archived Clinical Trial Blood Samples at 2013 American Association of Cancer Research Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... NEW YORK , Sept. 3, 2015 /PRNewswire/ ... blood glucose device is a home-based electronic device. ... transmitter that transmits information about glucose levels through ... it is displayed. The regular usage of self-monitoring ... and prompt an individual to undergo proper diabetes ...
(Date:9/3/2015)... NEW YORK , Sept. 3, 2015 About ... in dryness of eyes due to deficient tear production ... This syndrome is of two types: aqueous tear deficient ... deficient dry eye, lacrimal glands do not produce enough ... eye. Meibomian glands secrete lipids to slow tear evaporation ...
(Date:9/3/2015)... ALISO VIEJO, Calif. , Sept. ... ), a leading global pharmaceutical company, and AqueSys, ... focused on developing ocular implants that reduce intraocular ... they have entered into an agreement under which ...  Under the terms of the agreement, Allergan will ...
Breaking Medicine Technology:Global Self-monitoring Blood Glucose Devices Market 2015-2019 2Global Dry Eye Syndrome Market 2015-2019 2Allergan to Acquire Glaucoma Treatment Company AqueSys to Add Minimally Invasive Implantable Shunt to Eye Care Offering 2Allergan to Acquire Glaucoma Treatment Company AqueSys to Add Minimally Invasive Implantable Shunt to Eye Care Offering 3Allergan to Acquire Glaucoma Treatment Company AqueSys to Add Minimally Invasive Implantable Shunt to Eye Care Offering 4Allergan to Acquire Glaucoma Treatment Company AqueSys to Add Minimally Invasive Implantable Shunt to Eye Care Offering 5Allergan to Acquire Glaucoma Treatment Company AqueSys to Add Minimally Invasive Implantable Shunt to Eye Care Offering 6
... device to identify the, lipid core (fatty) coronary plaques ... ... Mass., May 15 InfraReDx, Inc. today,announced that physicians at ... Coronary Imaging System in a patient,undergoing a cardiac catheterization. This ...
... BONITA SPRINGS, Fla., May 15 Tigris Pharmaceuticals,Inc. ... and,Development Agreement (CRADA) with the National Cancer Institute ... AFP-464, an,aminoflavone currently in Phase I development. AFP-464 ... resulting in p53 activation and,apoptosis., This is ...
Cached Medicine Technology:First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 2First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 3First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 4Tigris Pharmaceuticals Signs CRADA with the National Cancer Institute 2Tigris Pharmaceuticals Signs CRADA with the National Cancer Institute 3
(Date:9/3/2015)... ... 2015 , ... BedJet released a new version of its award winning personal ... the BedJet v2 pre-order campaign blazed past the $1 million dollar mark ... on crowdfunding giant Kickstarter. , Simple to use and beautifully designed, the award winning ...
(Date:9/3/2015)... ... ... Real Time Pain Relief (RTPR), makers of the popular rub-on pain ... an official endorsement deal with the company. Originally from New South Wales, Australia, Mason ... 15. He is an Australian bull riding champion, following in his uncles’ footsteps in ...
(Date:9/3/2015)... ... 03, 2015 , ... Hope For The Warriors® is pleased ... are awarded two times each year to spouses or caregivers of post-9/11 wounded ... to restoring a sense of self, restoring the family unit, and restoring hope ...
(Date:9/3/2015)... ... September 03, 2015 , ... ... graduated compression garments. However, graduated compression garments are an effective solution for reducing ... specialist, Robyn Bjork, was recently sponsored by SIGVARIS for a unique ...
(Date:9/3/2015)... ... 03, 2015 , ... RealtyShares , the online marketplace ... investors to real estate investment opportunities nationwide, today announced that it is introducing ... and sponsoring real estate companies. , These products typically involve investors ...
Breaking Medicine News(10 mins):Health News:BedJet Hits $1 million in Sales in 28 Days on Kickstarter after Shark Tank Rejection 2Health News:BedJet Hits $1 million in Sales in 28 Days on Kickstarter after Shark Tank Rejection 3Health News:Real Time Pain Relief Sponsors the Talented PBR Bull Rider from Down Under - David Mason 2Health News:Real Time Pain Relief Sponsors the Talented PBR Bull Rider from Down Under - David Mason 3Health News:Hope For The Warriors Spouse/Caregiver Scholarships Now Open for Spring 2016 2Health News:SIGVARIS Supports the Lymphedema Treatment Act to Help Patients with Lymphedema 2Health News:SIGVARIS Supports the Lymphedema Treatment Act to Help Patients with Lymphedema 3Health News:RealtyShares Announces Mezzanine Financing Products 2Health News:RealtyShares Announces Mezzanine Financing Products 3
... that may put people with schizophrenia at risk for ... in altered brain activity in schizophrenia is not clear. ... at the University of Pennsylvania have come together using ... unique high-speed imaging technique - to understand how schizophrenia ...
... , THURSDAY, Oct. 13 (HealthDay News) -- Human children are ... a new study finds. Researchers compared the responses of ... Republic of Congo sanctuary. Both the children and the ... own or with a partner. Individuals could pull two ends ...
... Reporter , THURSDAY, Oct. 13 (HealthDay News) -- The symptoms ... come on weekdays, specifically when your child should be heading ... and it can take different forms in many age groups. ... school avoidance "remains a serious problem," said Alan Hilfer, director ...
... This press release is available in Spanish ... Department of Agriculture (USDA) and published recently in the journal ... new varieties of broccoli have not declined since 1975, and ... iron, magnesium, potassium and other minerals that have made the ...
... the International Osteoporosis Foundation (IOF) is releasing a 24-page ... strong muscles. Professor Heike Bischoff-Ferrari, director Centre ... City Hospital and author of the report, stated, "Put ... optimize your bone health by following three essential steps." ...
... exposed to tobacco smoke for a period of months, researchers ... disease (COPD) develops. In the October 14th issue of ... a promising new way to reverse the lung damage underlying ... clear what causes the disease and there has been no ...
Cached Medicine News:Health News:Penn team links schizophrenia genetics to disruption in how brain processes sound 2Health News:Young Children Collaborate Better Than Chimps 2Health News:Why Johnny Won't Go to School 2Health News:Why Johnny Won't Go to School 3Health News:USDA research demonstrates new breeds of broccoli remain packed with health benefits 2Health News:Three steps to unbreakable bones on World Osteoporosis Day 2Health News:Reversing smoke-induced damage and disease in the lung 2
VerdaSee Dock Door Portal ID solutions provide high performance tracking of assets that enter or leave healthcare facilities through dock doors....
The AeroScout Exciter extends the AeroScout system to provide robust and sophisticated RFID detection capabilities....
... Location-ID™ product solutions were developed to assist ... assets. To maximize use of existing capital ... increase the productivity of their employees, organizations ... track their valuable assets and ensure those ...
Radianse indoor positioning supports healthcare asset management with a way to locate medical equipment, devices and other portable assets....
Medicine Products: